GenKOre
Latest round
- Series A
Last raised
- Oct 2022
Total raised
- $15M
Investors
- 6
About GenKOre
, Ltd. edits both plant and animal genes to improve health conditions. The company offers gene editing for both plants and animals, which helps in improving health conditions. The firm provides genome editing technology which is a group of technology that provides the ability of scientists to change the DNA of organisms. Additionally, the company also offers a therapeutic approach.
Who invested in GenKOre
6 investors across 2 rounds
See all investors in GenKOre
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GenKOre
Who invested in GenKOre?
GenKOre has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenKOre raised?
GenKOre has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GenKOre last raise money?
GenKOre's most recent round on record is a Series A, in Oct 2022.
What does GenKOre do?
GenKOre is a biotechnology company.
Where is GenKOre headquartered?
GenKOre is headquartered in Daejeon, South Korea.
Which VCs invest in companies like GenKOre?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GenKOre's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GenKOre? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.